Navigation Links
Errors involving medications common in outpatient cancer treatment
Date:12/30/2008

WORCESTER, Mass. Seven percent of adults and 19 percent of children taking chemotherapy drugs in outpatient clinics or at home were given the wrong dose or experienced other mistakes involving their medications, according to a new study led by Kathleen E. Walsh, MD, assistant professor of pediatrics at the University of Massachusetts Medical School, and published in the January 1, 2009 issue of the Journal of Clinical Oncology.

"As cancer care continues to shift from the hospital to the outpatient setting, the complexity of care is increasing, as is the potential for medication errors, particularly in the outpatient and home settings," said Dr. Walsh, who is also a Robert Wood Johnson Physician Faculty Scholar.

An analysis of data on nearly 1,300 patient visits at three adult oncology outpatient clinics and 117 visits at one pediatric facility between September 1, 2005 and May 31, 2006 showed that errors in medication were more common than previously reported by oncology patients.

Of the 90 medication errors involving adults, 55 had the potential to harm the patient and 11 did cause harm. The errors included administration of incorrect medication doses due to confusion

over conflicting orders one written at the time of diagnosis and the other on the day of administration. Patients were also harmed by over-hydration prior to administration of medication, resulting in pulmonary edema and recurrent complaints of abdominal pain and constipation. More than 50 percent of errors involving adults were in clinic administration, 28 percent in ordering of medications, and 7 percent in use of the drugs in patients' homes.

About 40 percent of the 22 medication errors in children had the potential to cause harm and four children were harmed. More than 70 percent of the errors in children occurred at home. Examples of pediatric errors included parents giving the wrong dose or the wrong number of doses per day of medicin
'/>"/>

Contact: Jim Fessenden
james.fessenden@umassmed.edu
508-856-2000
University of Massachusetts Medical School
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
2. US adults most likely to report medical errors and skip needed care due to costs
3. Eye Surgery Errors Rare But Serious
4. InfoLogix Featured in FOX Business News Interview on Reducing Healthcare Medication Errors - Video Available Online
5. Pharmacists believe drive-through windows contribute to delays, errors
6. U.S. Pharmacopeia 8th Annual MEDMARX(R) Report Indicates Look-Alike/Sound-Alike Drugs Lead to Thousands of Medication Errors Nationwide
7. Unintended Errors Leave Many Newborns Vulnerable
8. New strategy helps reduce errors in obstetrical care
9. Depression in Young Doctors Tied to Medication Errors
10. Schizophrenia Tied to Multiple Genetic Errors
11. Anthem Blue Cross and Blue Shield in Wisconsin Announces Initiative Aimed at Preventing Serious Medical Errors; Company Committed to Protecting Members Health and Finances by Not Reimbursing Major Preventable Adverse Events

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ding U.S. air ambulance company now the only world...tion and Department of Defense approval, , ...9, 2009 -- AirMed International, the leading U.S. ...ed full accreditation from the European Aero-Medic...many, based non-profit association of air medical ...
(Date:11/9/2009)... of the top cosmetic surgeons in Dallas and a &ldq...ichis, MD, FACS, has recently published his new, h...in the Facial Plastic Surgery Clinics of North Ame...Reconstructive Surgeon, Dr. Bassichis’ innov...al filler treatments to achieve the most natural, ...
(Date:11/9/2009)...young athletes are under increasing pressure to pl... University Health System study of 519 junior tenn...eases the risk of injury. Researchers who analyzed... junior competition found that players who special...rom tournaments for medical reasons, typically inj...
(Date:11/8/2009)...ewswire-USNewswire/ -- Today, the nation Mayors co...ng, the Affordable Health Care for America Act, a ...ep in reforming America,s healthcare system. ,,...eting in Providence (RI), mayors from across the n... principles of reducing the long-term growth of he...
(Date:11/8/2009)...RNewswire-USNewswire/ -- The American Public Healt...ellness provisions in the health reform bill passe...this bill, the House takes important steps toward ... reforms and moving our health system from one tha... on keeping people healthy," said Georges C. Benja...
Breaking Medicine News(10 mins):Health News:AirMed International, Top U.S. Air Ambulance, Receives EURAMI Accreditation 2Health News:Dallas Facial Plastic Surgeon Publishes Cutting-Edge Novel Approach To Facelift Technique 2Health News:Young tennis players who play only 1 sport are more prone to injuries 2Health News:The Nation's Mayors Commend House Passage of Health Reform Bill 2Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2
...lecular Corporation, a,pioneer in the development ...lysis systems, announced today that Fran Tuttle ha.... Tuttle is president and chief executive,officer ...ard," said Xceed,s President and,CEO, David Deems....
...as released,today by the U.S. Department of Justic...m Ronald Tenpas, acting Assistant Attorney,General...n here at the,Department of Justice. Joining me to...nmental enforcement,settlement in the history of o...
...use study shows , TUESDAY, Oct. 9 (HealthDay News)...that may lead to a treatment for the hereditary, p...on,s disease (HD). , In mice, a molecule called C2... Disorders (MIND), Boston. Their study appears in ...
...finds , , TUESDAY, Oct. 9 (HealthDay News)...dren who,ve lost weight keep it off, new research ... effect of the maintenance programs wears off over...tudy. Clearly, maintenance treatment was better th...
...ose in commercial managed-care plans, study says ,...icaid enrollees receive lower quality health care ...tients in commercial health plans, a new study fou...nts. , "The policy message is that to the extent t...
...eveloped a potentially novel way to fight colorect...arrages of radiation inside cancer cells, unlike c...s and attack from the outside and cause unwanted s... cells, and whats left over is likely to be easily...
Other Medicine News:Health News:Xceed Molecular Names Fran Tuttle to Its Board of Trustees 2Health News:Transcript of Press Conference Announcing Settlement in United States Et Al vs. American Electric Power 2Health News:Transcript of Press Conference Announcing Settlement in United States Et Al vs. American Electric Power 3Health News:Transcript of Press Conference Announcing Settlement in United States Et Al vs. American Electric Power 4Health News:Transcript of Press Conference Announcing Settlement in United States Et Al vs. American Electric Power 5Health News:Transcript of Press Conference Announcing Settlement in United States Et Al vs. American Electric Power 6Health News:Transcript of Press Conference Announcing Settlement in United States Et Al vs. American Electric Power 7Health News:Transcript of Press Conference Announcing Settlement in United States Et Al vs. American Electric Power 8Health News:Transcript of Press Conference Announcing Settlement in United States Et Al vs. American Electric Power 9Health News:Molecule Promising Against Huntington's Disease 2Health News:Maintenance Treatment Helps Kids Keep Weight Off 2Health News:Maintenance Treatment Helps Kids Keep Weight Off 3Health News:Maintenance Treatment Helps Kids Keep Weight Off 4Health News:Medicaid Managed Care Seems to Fall Short 2Health News:Medicaid Managed Care Seems to Fall Short 3Health News:Medicaid Managed Care Seems to Fall Short 4Health News:Inside job: new radioactive agents for colon cancer work inside cells 2
(Date:11/6/2009)..., Nov. 6 NuVasive, Inc. ... on developing products for minimally disruptive s...the appointment of Michael J. Lambert as Executive...tive November 9, 2009. The Company also announced...,, "Michael will be an excellent complement to ...
(Date:11/6/2009)... Manitoba, Nov. 6 With his propose...has set his sights on cutting name-brand prescript... who fall into the "Part D" coverage gap, universa... about the potential cost-cutting and feel it,s a ... the most powerful lobbyists want a revised progra...
(Date:11/6/2009)...Nov. 6 Cyberonics, Inc. ...will report financial results for the second quart...g April 30, 2010 on Wednesday, November 18, 2009 a...nce call to discuss those results on Thursday, Nov... 2010 Second Quarter Results Conference Call Instr...
Breaking Medicine Technology:NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 1Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 2Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 3Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 4Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 5Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 6Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 7Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 8Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 9Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 10Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 11Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 12Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 13Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 14Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 15Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 16Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 17Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 18Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 19Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 20Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 21Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 22Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 23Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 24Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 25Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 26Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 27Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 28Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 29Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 30Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 31DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 1DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 2DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 3DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 4Nfocus Neuromedical Announces US Clearance of Unique Guiding Catheter with Uni body Internal Skeleton 54719 1Nfocus Neuromedical Announces US Clearance of Unique Guiding Catheter with Uni body Internal Skeleton 54719 2
...tors to Better Target Patients for ALIMTA(R), (pem...ll Cell Lung Cancer, BARCELONA, Spain, Sept. 25 ...mall cell lung cancer (NSCLC) that,are classified ...ically,significant higher survival when treated in...d for injection) when compared to,histologically-s...
... (DSMB) Authorizes Enrollment of Cervical ...el, HOPKINTON, Mass., Sept. 24 Alseres,Pharmaceu...ndependent Data,Safety Monitoring Board (DSMB) has...ase I/IIa clinical trial in acute spinal cord inju... treated with a 9 mg dose of,Cethrin(R). This reco...
Other Medicine Technology:Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 2Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 3Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 4Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 5Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 6Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 7Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 8Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 2Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 3Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 4Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 5
...ed ratchet design provides fingertip ratchet disen... ,The Series I Instrument program offers state-of-...profile, while maintaining strength and durability...gy in tight joint spaces. Series I instruments are...
Graspers Alligator
Scissors Punches
Basket Punches Scoop
Medicine Products: